Case report:
Mrs Rafia Khatoon, 73 years old, hypertensive, dyslipidaemic, nondiabetic, Bangladeshi lady admitted with complaints of vertigo, uncontrolled blood pressure, intermittent weakness of right lower limb for two days. On physical examination she was of average built having plethoric face & conjunctival injection. She had an overall dusky cyanotic complexion. Her pulse was 60 bpm, regular, BP was 250/110 mm of Hg. No other positive findings like hepato-splenomegaly or weakness of any part of the body were present. She had H/O admission on 1992 for accelerated hypertension. A provisional diagnosis of polycythemia rubra vera was made & blood was sent for investigation.
Investigations revealed hemoglobin 17.50 gm/dl ( N-12 to 16 gm/dl), red cell count 8.91 million/µl ( N-3.5 to 6 M/µl), Hct. 58.50% ( N-37 to 52%), MCV 65.70fL (67 to 96 fL), MCH 19.60 pg ( N 27 to 32 pg), WBC 13.11 k/µl ( N 150-450 k/µl) with ESR 02 mm in Ist hour. PBF showed erythrocytosis, thrombocytosis with microcytic hypochromic blood picture, leukocytosis. Her bilirubin level was upper limit of normal ( 1.78 mg/dl, range was .2 to 1.3 mg/dl) & uric acid level was 10.10 mg/dl (N-2.5 to 6.2).
High blood level of hemoglobin, PCV & a raised platelet count with leukocytosis aroused the suspicion of PRV. Taking all the above parameters into account & in consultation with a hematologist she had undergone bonemarrow (Fig.-1 She was treated with phlebotomy twice (at an interval of 7 days), Tab Hydroxyurea (500 mg/day), Tab. Ecosprin (75mg/day), Tab Esloric , Beta-blocker, ACEI, Calcium channel blocker & Proton pump inhibitor.
Discussion:
Polycythaemia rubra vera occurs in all age groups, 10 one study found although the incidence increases with age, the median age at diagnosis to be 60 years. 11 About a third presents with symptoms due to thrombosis. Three quarters of this is arterial thrombosis and a quarter is venous thrombosis. Features include stroke, MI, DVT and pulmonary embolism. Quantitative platelet derangement plays a role in the development of thrombosis and ischemia which leads to increased incidence of stroke, MI and arterial or venous thrombosis. 12 Hypertension is common in patient with PRV. This case report outlines the investigation and management of a patient who developed a neurological syndrome due to PRV. The diagnostic workup includes hematological investigations and imaging studies, including CT. The management of this patient includes initial treatment of stroke & hypertension. Further specific treatment should be directed towards the management of the hematological condition that is responsible for the neurological event. In the majority of the cases anti-platelet treatment will be appropriate with either aspirin 13 or clopidogrel. 14 The characteristics pathological processes of PRV, via cerebrovascular occlusion, could lead to TIA/stroke. In a patient of PRV, the management is only to prevent thrombotic complication & to maintain normal haematocrit level by doing periodic phlebotomies. Hydroxyurea or Interferon-a or anegrilide can be given to control thrombocytosis. 15 In our case the patient was diagnosed & treated earlier, because of which she rescued from developing of frank feature of stroke. Hence any case presenting with TIA/ stroke like feature should always necessitate a thorough clinical, hematological & radiological workup.
Fig-1: Bone marrow film demonstrating dominance of erythropoiesis

